Health Care 

VARON Introduces VP-8 Lite: Portable, Reliable Oxygen Support to Start 2026

As 2026 begins, many people are setting goals to live healthier, stay active, and take control of their well-being. For those who rely on supplemental oxygen, maintaining optimal respiratory health is a key part of...

VARON Introduces VP-8 Lite: Portable, Reliable Oxygen Support to Start 2026
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50...

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including an overview of key corporate objectives for 2026. The company will review these updates during...

IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
/C O R R E C T I O N -- United One Group (UOG) America/

United One Group Healthcare (UOG), the developer of the world's first Black Diamond Carbon & Nano Silver fusion wellness technology, announced today that it has been honored with three major industry awards at CES...

/C O R R E C T I O N -- United One Group (UOG) America/
UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

United One Group Healthcare (UOG), the developer of the world's first Black Diamond Carbon & Nano Silver fusion wellness technology, announced today that it has been honored with three major industry awards at CES...

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026
RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Johnson & Johnson (NYSE:JNJ) today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor...

RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer
Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)

PPL proudly announces it has achieved an impressive score of 63 on the 2025 S&P Global CSA. This marks a substantial 15% improvement over last year's score of 55, reflecting the Company's ongoing commitment to...

Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
/C O R R E C T I O N -- Mu Medical/

Nanodropper, the leader in micro-volume ophthalmic delivery, today announced that Bedo Solutions and Viseon Labs have agreed on terms to join its precision eyecare platform under a new corporate identity: Mu Medical.

/C O R R E C T I O N -- Mu Medical/
Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs

Nanodropper, the leader in micro-volume ophthalmic delivery, today announced that Bedo Solutions and Viseon Labs have agreed on terms to join its precision eyecare platform under a new corporate identity: Mu Medical.

Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
/C O R R E C T I O N -- Illuminate Rx/

Illuminate Rx, a pharmacy benefits manager (PBM) and affiliate of RxBenefits, Inc., today announced the appointment of Ritu Malhotra, PharmD, as President. With more than two decades of experience transforming healthcare...

/C O R R E C T I O N -- Illuminate Rx/
/C O R R E C T I O N -- AmplifyMD/

AmplifyMD, the AI-enabled multispecialty virtual care platform transforming how health systems scale physician capacity, today announced the appointment of two of the nation's most influential healthcare leaders to its...

/C O R R E C T I O N -- AmplifyMD/
Lucent Health Names Aadam Hussain as Chief Executive Officer Following Brett Rodewald's Retirement

Today, Lucent Health, one of the nation's largest independent third-party administrators, announced the appointment of Aadam Hussain as Chief Executive Officer, effective January 5, 2026.

Lucent Health Names Aadam Hussain as Chief Executive Officer Following Brett Rodewald's Retirement
Illuminate Rx Appoints Industry Veteran Ritu Malhotra, PharmD, as President to Advance Clarity in Pharmacy Benefits

Illuminate Rx, a pharmacy benefits manager (PBM) and affiliate of RxBenefits, Inc., today announced the appointment of Ritu Malhotra, PharmD, as President. With more than two decades of experience transforming healthcare...

Illuminate Rx Appoints Industry Veteran Ritu Malhotra, PharmD, as President to Advance Clarity in Pharmacy Benefits
ENA Foundation Announces 2026 Board of Trustees

The ENA Foundation has announced its 2026 Board of Trustees, which will be chaired by Kimberly Russo, MSN, RN, CEN, TCRN, an emergency department nurse manager at University Hospital in Newark, New Jersey.

ENA Foundation Announces 2026 Board of Trustees
Nicklaus Children's Hospital Earns Fourth Consecutive Top Children's Hospital Award by The Leapfrog Group for Outstanding Quality and Safety

Highlighting its nationally recognized achievements in patient safety and quality, Nicklaus Children's was named a Top Children's Hospital by The Leapfrog Group. This award is one of the most competitive honors...

Nicklaus Children's Hospital Earns Fourth Consecutive Top Children's Hospital Award by The Leapfrog Group for Outstanding Quality and Safety
Continued Zenocutuzumab Treatment Beyond Progression Shows Benefit in Patients with NRG1+ Pancreatic Cancer and Cholangiocarcinoma: New Results from the eNRGy Trial Presented at ASCO GI

Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announced new data from a post hoc analysis of the eNRGy trial (NCT02912949), evaluating zenocutuzumab in patients with advanced...

Continued Zenocutuzumab Treatment Beyond Progression Shows Benefit in Patients with NRG1+ Pancreatic Cancer and Cholangiocarcinoma: New Results from the eNRGy Trial Presented at ASCO GI
Newsweek Ranks Mary Free Bed at Home Among America's Best Home Health Agencies 2026

Mary Free Bed at Home is proud to be named among America's Best Home Health Agencies for 2026 by Newsweek and Statista. Ranked fifth in the state of Michigan, and first in West Michigan, this prestigious recognition...

Newsweek Ranks Mary Free Bed at Home Among America's Best Home Health Agencies 2026
CVS Health to hold fourth quarter and full year 2025 earnings conference call

CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results.

CVS Health to hold fourth quarter and full year 2025 earnings conference call
Prescryptive and Ilant Health Expand Employer-Direct Access to Obesity Care and Transparent GLP-1 Access at Scale

Prescryptive and Ilant Health today announced a collaboration to help employers access transparent GLP-1 pricing alongside expert, outcomes-driven clinical care.

Prescryptive and Ilant Health Expand Employer-Direct Access to Obesity Care and Transparent GLP-1 Access at Scale
Major Medical Devices Secures Strategic Funding to Advance Novel AAA Repair Device to Market

Major Medical Devices, Inc. (http://www.majormedicaldevices.com) (MMD), an emerging innovator in vascular intervention technologies with a highly differentiated, potentially quick to market device in a $3 billion market,...

Major Medical Devices Secures Strategic Funding to Advance Novel AAA Repair Device to Market
Encompass Health announces date of 2025 fourth quarter earnings call

Encompass Health Corp. (NYSE: EHC) today announced it will report results for its fourth quarter ended Dec. 31, 2025, after the market closes on Thursday, Feb. 5, 2026. The Company will host an investor conference call at...

Encompass Health announces date of 2025 fourth quarter earnings call
WearOptimo Strengthens Intellectual Property Portfolio with Issuance of Additional Patents to Support Wearable Sensor Technology for Health Monitoring

WearOptimo, a healthcare technology company developing next-generation Microwearable sensors for hydration and biomarker monitoring, today announced three new granted patents, expanding WearOptimo's intellectual...

WearOptimo Strengthens Intellectual Property Portfolio with Issuance of Additional Patents to Support Wearable Sensor Technology for Health Monitoring
Averna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Averna Therapeutics, Inc., a biotechnology company developing novel genomic medicines based on gene insertion technology, today announced that Tom Barnes, Ph.D., Chief Executive Officer, will present at the 44th Annual...

Averna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
DiMe launches new initiative to scale trusted, high-impact AI care navigation in response to how patients are already using AI to navigate care

Yesterday, the Digital Medicine Society (DiMe) announced the launch of Scaling Trusted, High-Impact AI Care Navigation, a new multi-stakeholder initiative convening leaders from technology, healthcare delivery, patient...

DiMe launches new initiative to scale trusted, high-impact AI care navigation in response to how patients are already using AI to navigate care
GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder

GRIN Therapeutics, Inc., a leader in the development of targeted disease-specific therapies for serious neurodevelopmental disorders, today announced that it has dosed the first patient in its global Phase 3 Beeline trial...

GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder
Kroger Announces the Sale of Vitacost.com, Inc.

The Kroger Co. (NYSE: KR) today announced the sale of its subsidiary, Vitacost.com, Inc., an eCommerce retailer of health and wellness products, to iHerb. The transaction closed on January 8.

Kroger Announces the Sale of Vitacost.com, Inc.
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal disease, will accelerate its share buyback program and start the repurchase of the second tranche. The...

Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
Find Therapeutics Announces Series A Extension Financing and Appointment of Dr. Thierry Abribat as Executive Chairman of the Board

MONTREAL, Jan. 9, 2026 /PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for demyelinating diseases, today announced that it closed its Series A Extension...

Find Therapeutics Announces Series A Extension Financing and Appointment of Dr. Thierry Abribat as Executive Chairman of the Board
Nona Biosciences Enters into Collaboration Agreement with Link Cell Therapies to Advance CAR-T Cell Therapies

Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology platforms, today announced that it has entered into a multi-target antibody discovery collaboration with...

Nona Biosciences Enters into Collaboration Agreement with Link Cell Therapies to Advance CAR-T Cell Therapies
MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche

MediLink Therapeutics ("MediLink") today announced that it has entered into a new collaboration and exclusive licensing agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) for the development and commercialization of YL201,...

MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche
Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular...

Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
PRIVACY ALERT: Covenant Health, Inc. Under Investigation for Data Breach of Over 470,000 Patient Records

Schubert Jonckheer & Kolbe LLP is investigating a data breach that led to unauthorized access to the sensitive information of 478,188 patients of Covenant Health, Inc. ("Covenant"), a Massachusetts-based not-for-profit...

PRIVACY ALERT: Covenant Health, Inc. Under Investigation for Data Breach of Over 470,000 Patient Records
Antheia CEO Joins Fierce JPM Week as Panelist Speaker on Onshoring Pharmaceutical Supply Chains

Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, today announced that CEO and co-founder, Dr. Christina Smolke will join Fierce JPM Week as a featured...

Antheia CEO Joins Fierce JPM Week as Panelist Speaker on Onshoring Pharmaceutical Supply Chains
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 44th Annual J.P. Morgan Conference on Monday, January 12, 2026, at...

BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today provided corporate updates and highlights from its ZYNLONTA® clinical program.

ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates
CREATE Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference

CREATE Medicines, Inc. ("CREATE" or the "Company"), a clinical-stage biotechnology company pioneering in vivo CAR therapy, today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San...

CREATE Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
BioLab Holdings Announces Significant Team Growth Across Key Departments

BioLab Holdings, Inc. is proud to share its continued expansion and commitment to creating jobs and improving economic impact for its community. Over the past year, the Arizona-based medical manufacturer specializing in...

BioLab Holdings Announces Significant Team Growth Across Key Departments
BRIJ Medical Oversubscribes Recent Fundraising Round Ahead of Expansion and Next-Gen Product Launch

BRIJ Medical, the company redefining surgical closure and post-surgical healing with active tension offloading, today announced that it has successfully oversubscribed its SAFE fundraising round, surpassing its initial...

BRIJ Medical Oversubscribes Recent Fundraising Round Ahead of Expansion and Next-Gen Product Launch
New Dietary Guidelines Emphasize Protein and Recommend Eggs as a High-Quality, Nutritious Choice for Americans at Every Age

The 2025-2030 Dietary Guidelines encourage Americans to prioritize protein at every meal and list eggs first among recommended protein foods. This guidance reinforces eggs' long-standing...

New Dietary Guidelines Emphasize Protein and Recommend Eggs as a High-Quality, Nutritious Choice for Americans at Every Age
CourtsApp Launches as "The Healthiest App in the World," Turning Screen Time Into Play Time

CourtsApp, the first AI-powered marketing and booking platform with thousands of courts available at discounted prices, is ringing in the New Year redefining what App health technology looks like by getting people off...

CourtsApp Launches as "The Healthiest App in the World," Turning Screen Time Into Play Time
FUGO Precision 3D and Graphy Forge Strategic Partnership to Accelerate Advanced Material Integration Ahead of LMT 2026 Launch

FUGO Precision 3D, a pioneering force in next-generation additive manufacturing, has entered into a strategic partnership with South Korean materials innovator Graphy Inc. (KOSDAQ: 318060), marking a critical milestone in...

FUGO Precision 3D and Graphy Forge Strategic Partnership to Accelerate Advanced Material Integration Ahead of LMT 2026 Launch
Americares and CAA Volunteers Promote Disaster Preparedness on LA Wildfires Anniversary

Leading entertainment and sports agency Creative Artists Agency (CAA) and global health and disaster relief organization Americares marked one year since the devastating Los Angeles wildfires by helping area residents...

Americares and CAA Volunteers Promote Disaster Preparedness on LA Wildfires Anniversary
ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY PLATFORM

Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today the expansion of its scientific and clinical...

ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY PLATFORM
What a Better VA Benefits Process Could Look Like--Without Leaving Veterans Behind

My name is Ryan Hawley. I work in veteran healthcare and medical documentation, and I spend a lot of time talking with veterans who are trying to navigate the VA disability benefits process. Most of them aren't angry...

What a Better VA Benefits Process Could Look Like--Without Leaving Veterans Behind
FORMER NFL STARS TEAM UP WITH CDC TO TACKLE LUNG CANCER IN "GEAR UP AGAINST CANCER" CAMPAIGN

The National Football League Alumni Association (NFL Alumni) and the Centers for Disease Control and Prevention (CDC) Division of Cancer Prevention and Control have expanded the "GEAR UP Against Cancer" campaign to Dallas,...

FORMER NFL STARS TEAM UP WITH CDC TO TACKLE LUNG CANCER IN "GEAR UP AGAINST CANCER" CAMPAIGN
DELFI Diagnostics Appoints Cindy Soriano as Chief Financial Officer and Announces Participation in 44th Annual J.P. Morgan Healthcare Conference

DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, today announced the appointment of Cindy Soriano as Chief Financial Officer,...

DELFI Diagnostics Appoints Cindy Soriano as Chief Financial Officer and Announces Participation in 44th Annual J.P. Morgan Healthcare Conference
Doceree Emerges as Healthcare Marketing's Most AI-Forward Technology Platform, Building Industry's First Operating System for the AI Era

Doceree, the world's first AI-powered Operating System for healthcare marketing, today announced its emergence as the most AI-forward technology platform in the category, marking 2025 as the year it moved the industry...

Doceree Emerges as Healthcare Marketing's Most AI-Forward Technology Platform, Building Industry's First Operating System for the AI Era
SU2C DREAM TEAM TARGETS EARLY DETECTION OF GASTRIC CANCER

Stand Up To Cancer® (SU2C) and Cancer Research UK announced today new support for a dream team focused on stopping gastric cancer in its earliest stages. The extended funding for the SU2C Gastric Cancer Interception Dream...

SU2C DREAM TEAM TARGETS EARLY DETECTION OF GASTRIC CANCER
VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses

Astellas Pharma U.S., Inc. (Head of US Commercial: Mike Petroutsas, "Astellas") today announced the publication of exploratory ad hoc analyses from the combined Phase 3 SPOTLIGHT (NCT03504397) and GLOW (NCT03653507)...

VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses
Wellvana Appoints Jim Murray as President and Chief Financial Officer

Wellvana announced today that Jim Murray has been named President and Chief Financial Officer, effective immediately. In this role, Murray will oversee financial and operational functions as the company strengthens its...

Wellvana Appoints Jim Murray as President and Chief Financial Officer
Joel Zupnick Opens New SpecialtyRX Pharmacy Location in Austin, Texas

SpecialtyRx, a leading provider of pharmacy services, today announced the opening of its new pharmacy location in Austin, Texas, further expanding the company's presence in the state and strengthening its ability to...

Joel Zupnick Opens New SpecialtyRX Pharmacy Location in Austin, Texas
Medical Solutions partners with the Ohio Hospital Association to support Ohio hospitals' workforce needs

From urban health systems to rural community hospitals, organizations across Ohio lead a vital mission in caring for their communities. As businesses statewide continue to navigate evolving workforce challenges, Medical...

Medical Solutions partners with the Ohio Hospital Association to support Ohio hospitals' workforce needs
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, before the...

Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026
Mercy Joins Clinical Study for Blood Test That Screens for Multiple Types of Cancers

Mercy is participating in a study designed to evaluate the clinical impact of GRAIL's Galleri® multi-cancer early detection (MCED) test among Medicare beneficiaries.

Mercy Joins Clinical Study for Blood Test That Screens for Multiple Types of Cancers
Force Therapeutics Celebrates 2025 Research Impact

Force Therapeutics is proud to celebrate a landmark year of research achievements made possible by collaboration with our health care partners across the country. By leveraging Force Therapeutics' outcomes data and...

Force Therapeutics Celebrates 2025 Research Impact
Purina Spotlights Next Generation of Pet Care Innovation with 2026 Pet Care Innovation Prize Winners

Today, Purina – a global leader in pet care – announced the five startups selected as winners of its tenth annual Pet Care Innovation Prize, recognizing emerging companies that are shaping the future of pet health,...

Purina Spotlights Next Generation of Pet Care Innovation with 2026 Pet Care Innovation Prize Winners
New Research Highlights Distinct Support for Immune-Balancing Activity in Lion's Mane Mushroom Mycelium as Compared to Fruiting Body Extracts

New research published in the peer-reviewed science journal, Immuno, reports that Hericium erinaceus (Lion's Mane) off-the-shelf mushroom mycelium-based products may have distinct advantages when compared to hot water...

New Research Highlights Distinct Support for Immune-Balancing Activity in Lion's Mane Mushroom Mycelium as Compared to Fruiting Body Extracts
RealTime Laboratories' At-Home Mycotoxin Mold Testing Panel Now Available Direct-to-Consumer

RealTime Laboratories Inc., a medical and diagnostic laboratory specializing in mold and environmental toxin detection, today announces its Mycotoxin Panel and suite of at-home tests are now available for direct purchase...

RealTime Laboratories' At-Home Mycotoxin Mold Testing Panel Now Available Direct-to-Consumer
Francelys Infante Launches N2B4B: A Holistic Self-Care Brand Rooted in Resilience and Self-Worth

Enter N2B4B (Not Too Broke For Beauty), a wellness-driven beauty brand founded by Francelys Infante, whose powerful story of survival and transformation is reshaping the modern definition of self-care. Rooted in a mission...

Francelys Infante Launches N2B4B: A Holistic Self-Care Brand Rooted in Resilience and Self-Worth
CBCC Global Research Rebrands to REV Clinical to Reflect Next Stages of Growth

CBCC Global Research, a multi-national clinical contract research organization ("CRO") with deep experience in designing and managing clinical trials across its core therapeutic areas, including oncology, neurology,...

CBCC Global Research Rebrands to REV Clinical to Reflect Next Stages of Growth
From Quantified Meditation to Bio-Computing, All Here Launches the Bio-Intelligence Initiative

All Here announces the launch of the Bio-Intelligence Initiative, the world's first research program exploring how deep meditative states of stability and silence of Mind give rise to measurable neural patterns, and...

From Quantified Meditation to Bio-Computing, All Here Launches the Bio-Intelligence Initiative
Aspen Neuroscience Completes Phase 1/2a ASPIRO Trial Cohort Three Dosing and State-of-the-Art Manufacturing Expansion, Paving the Way for Developing Transformative Therapies for Patients

Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced completion of Cohort Three* dosing in the company's ASPIRO Phase 1/2a trial of ANPD001, a...

Aspen Neuroscience Completes Phase 1/2a ASPIRO Trial Cohort Three Dosing and State-of-the-Art Manufacturing Expansion, Paving the Way for Developing Transformative Therapies for Patients
Penny Houchens Named Executive Vice President of Healthcare at Gresham Smith

Gresham Smith, a leading architecture, engineering and consulting firm with more than $355 million in gross revenue, is proud to announce that Penny J. Houchens, IIDA, LEED AP, NCIDQ, Lean has been named Executive Vice...

Penny Houchens Named Executive Vice President of Healthcare at Gresham Smith
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has received a decision letter from the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) concluding that...

Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder
Probo Medical Names Mike Dilick CEO to Drive Next Phase of Growth

Probo Medical, a global leader in diagnostic imaging solutions, has appointed Mike Dilick as Chief Executive Officer, effective January 1, 2026, to accelerate the company's growth and innovation.

Probo Medical Names Mike Dilick CEO to Drive Next Phase of Growth
Lumexa Imaging Achieves Record De Novo Expansion in 2025

Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, set a company record by opening nine de novo centers in 2025. The two newest centers, located in Anderson, South...

Lumexa Imaging Achieves Record De Novo Expansion in 2025
VICHY LABORATOIRES INTRODUCES EMILY DIDONATO AS GLOBAL BRAND AMBASSADOR

Vichy Laboratoires, leader in dermocosmetics and recommended by more than 80,000 dermatologists worldwide, is proud to announce the signing of multihyphenate model and wellness advocate, Emily DiDonato, as the new face of...

VICHY LABORATOIRES INTRODUCES EMILY DIDONATO AS GLOBAL BRAND AMBASSADOR
Chinese Medical AI Team's MedGPT Tops Global Rankings in New Clinical Benchmark Published by Nature Portfolio Journal

A research team from China has introduced the first standardized framework for evaluating the clinical applicability of medical AI systems, with their findings published in npj Digital Medicine, a leading journal in the...

Chinese Medical AI Team's MedGPT Tops Global Rankings in New Clinical Benchmark Published by Nature Portfolio Journal
LumiMind To Showcase Groundbreaking Non-Invasive BCI Technology With Live Gameplay Demo at CES 2026

LumiMind, a next-generation neurotechnology company pioneering non-invasive, real-time neural modulation, will showcase breakthrough brain–computer interface (BCI) technology at CES 2026 in Las Vegas, including a live,...

LumiMind To Showcase Groundbreaking Non-Invasive BCI Technology With Live Gameplay Demo at CES 2026
Stay Fit, Stay Well -- The Fitness Industry Is Surging Worldwide

TaiSPO, Taiwan's Sports and Fitness Exhibition, will take place from March 25–28 at Taipei Nangang Exhibition Center Hall 2. Continuing the spirit of "Stay Fit, Stay Well," the event brings key players from the sports,...

Stay Fit, Stay Well -- The Fitness Industry Is Surging Worldwide
Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, Jan. 13, at...

Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that senior management will...

Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
USAPA: HHS Hands a Win to Big Alcohol

The U.S. Alcohol Policy Alliance (USAPA) today criticized the newly released 2025–2030 Dietary Guidelines for Americans (DGAs) for retreating from the best available science on alcohol's role in chronic disease and...

USAPA: HHS Hands a Win to Big Alcohol
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026

Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, February 5, 2026. The Company will hold a conference call with...

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
Lifeway Foods Applauds New Federal Dietary Guidelines Highlighting Protein, Full-Fat Dairy and Fermented Foods Like Kefir

Lifeway Foods, Inc. (Nasdaq: LWAY), the leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, today welcomed the release of the 2025–2030 Dietary Guidelines for Americans. These new...

Lifeway Foods Applauds New Federal Dietary Guidelines Highlighting Protein, Full-Fat Dairy and Fermented Foods Like Kefir
New AllOne Health Data Confirms EAP Role Shift: Employers Now Rely on EAPs as Strategic Organizational and Risk Management Partners

AllOne Health today announced findings from the largest multi-year analysis ever conducted on Employee Assistance Program (EAP) organizational consulting and formal management referral (FMR) services. The peer-reviewed...

New AllOne Health Data Confirms EAP Role Shift: Employers Now Rely on EAPs as Strategic Organizational and Risk Management Partners
Experts Stress Reducing Plastics in Homes as Los Angeles Rebuilds from Wildfires

On the anniversary of the January 2025 devastating wildfires in Los Angeles, California, experts at Plastic Pollution Coalition and Habitable stress the need to reduce plastics in homes and other buildings to reduce future...

Experts Stress Reducing Plastics in Homes as Los Angeles Rebuilds from Wildfires
Sentry® donates $1 million to support Maui nonprofits

Sentry is donating $1 million to three Maui-based nonprofit organizations in recognition of their vital contributions to community well-being, environmental restoration, and the island's continuing recovery.

Sentry® donates $1 million to support Maui nonprofits
NEW SURVEY: 74% of U.S. Adults Ready to Slow Aging in 2026 but Uncertain on Where to Start

A new nationwide survey of U.S. adults found that nearly three-quarters (74%) are willing to make major lifestyle changes in 2026 to slow biological aging, but say they are unsure how to begin. The poll, commissioned by...

NEW SURVEY: 74% of U.S. Adults Ready to Slow Aging in 2026 but Uncertain on Where to Start
Parallel ENT & Allergy Expands Texas Presence, Welcomes Three Leading Practices as Supported Partners

Parallel ENT & Allergy, a physician-centric practice management organization, is proud to announce the addition of three premier Texas practices as Parallel supported partners:

Parallel ENT & Allergy Expands Texas Presence, Welcomes Three Leading Practices as Supported Partners
JETSET Pilates Enters Arizona with Multi-Unit Deal and Eyes Further Expansion

JETSET Pilates, the fast-growing modern Reformer Pilates franchise offering premium, full-body workouts, has officially entered Arizona with a newly signed three-unit franchise agreement in Scottsdale. The deal marks the...

JETSET Pilates Enters Arizona with Multi-Unit Deal and Eyes Further Expansion
THE OHIO HEALTH CARE ASSOCIATION ANNOUNCES LEADERSHIP TRANSITION: SCOTT D. WILEY, CAE, NAMED CHIEF EXECUTIVE OFFICER

The Ohio Health Care Association (OHCA) today announced the board of directors' unanimous appointment of Scott D. Wiley, CAE, as chief executive officer effective January 2026.

THE OHIO HEALTH CARE ASSOCIATION ANNOUNCES LEADERSHIP TRANSITION: SCOTT D. WILEY, CAE, NAMED CHIEF EXECUTIVE OFFICER
Doctor's Best Celebrates FDA Decision on NMN Supplements, Relaunches Product Line

Doctor's Best, a leading nutritional supplement company, announces that its parent company, Xiamen Kingdomway Group, has received a New Dietary Ingredient (NDI) letter from the Food and Drug Administration (FDA) for...

Doctor's Best Celebrates FDA Decision on NMN Supplements, Relaunches Product Line
Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus

A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR)- even on days when...

Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus
Manage Transitions of Care from Admissions to Post-Discharge with the Next-Generation of Olio

Olio, built specifically for the complexity of skilled nursing, is designed to serve as the connective infrastructure for seamless care transitions. Skilled Nursing Operators face tightening margins, evolving CMS...

Manage Transitions of Care from Admissions to Post-Discharge with the Next-Generation of Olio
Marshall Mohr Joins Capstan Medical Board of Directors

Capstan Medical, a developer of robotic-enabled, minimally invasive solutions to address heart valve disease, today announced the appointment of Marshall Mohr to its Board of Directors to further advance the company's...

Marshall Mohr Joins Capstan Medical Board of Directors
Aspen Neuroscience Appoints Chief Commercial Officer Lisa Johnson-Pratt, M.D. and Welcomes Revati Shreeniwas, M.D., FCCP as Chief Medical Officer to Accelerate Late-Stage Development and Commercial Readiness

Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced two executive leadership appointments: Revati Shreeniwas, M.D., FCCP has joined Aspen as Chief...

Aspen Neuroscience Appoints Chief Commercial Officer Lisa Johnson-Pratt, M.D. and Welcomes Revati Shreeniwas, M.D., FCCP as Chief Medical Officer to Accelerate Late-Stage Development and Commercial Readiness
PLANET FITNESS RECOGNIZED FOR EXCEPTIONAL CUSTOMER SERVICE

Planet Fitness, one of the largest and fastest-growing franchisors and operators of fitness centers with more members than any other fitness brand, has been named to USA Today's America's Best Customer Service List...

PLANET FITNESS RECOGNIZED FOR EXCEPTIONAL CUSTOMER SERVICE
TeliosRx Consulting: Engineering Smarter Pharmacy Benefits

TeliosRx, an independent pharmacy benefit consulting firm, today announced its launch, offering fiduciary-aligned consulting services designed to optimize pharmacy benefits, manage costs, and ensure clinically appropriate...

TeliosRx Consulting: Engineering Smarter Pharmacy Benefits
FDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen Deficiency

Octapharma USA, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new 2-gram presentation of Fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for fibrinogen replacement...

FDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen Deficiency